Search Results - "Chitour, Kerim"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children by USONIS, VYTAUTAS, BAKASENAS, VYTAUTAS, KAUFHOLD, ACHIM, CHITOUR, KERIM, CLEMENS, RALF

    Published in The Pediatric infectious disease journal (01-01-1999)
    “…OBJECTIVE.To compare the reactogenicity and immunogenicity of a novel live attenuated measles-mumps-rubella vaccine, SB MMR (Priorix; SmithKline Beecham…”
    Get full text
    Journal Article
  2. 2

    Potent and Durable Neutrophil Stimulation and Progenitor Stem Cell Mobilization by Maxy-G34 a Next Generation G-CSF by Vetticaden, Santosh J., Apt, Doris, Chitour, Kerim, Goldwater, Ronald

    Published in Blood (16-11-2007)
    “…Introduction: Maxy-G34 is a PEGylated, recombinant human G-CSF that has been modified to reduce both renal and G-CSF receptor-mediated clearance, thereby…”
    Get full text
    Journal Article
  3. 3

    Varicella vaccination of health-care workers by Burgess, Margaret A, Cossart, Yvonne E, Wilkins, T.Douglas, Botham, Sue, Fearns, Grace, Chitour, Kerim

    Published in Vaccine (26-02-1999)
    “…The objective of this open study was to evaluate the response of non-immune health-care workers to two doses of live attenuated varicella vaccine given two…”
    Get full text
    Journal Article
  4. 4

    A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age by GATCHALIAN, S, CORDERO-YAP, L, LU-FONG, M, SORIANO, R, LUDAR, A, CHITOUR, K, BOCK, H. L

    “…An open, randomized multi-center trial, involving 700 infants, was conducted in order to compare a new measles mumps rubella (MMR) vaccine, SB MMR (containing…”
    Get full text
    Journal Article